Clinical Trials Browser

Phase 2 × INDUSTRY × Drug Therapy, Combination × Clear all

NCT00079482 2016-07-21

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute